Lack of association between the insulin receptor substrates-1 Gly972Arg polymorphism and type-2 diabetes mellitus among Saudis from Eastern Saudi Arabia

References

1. ↵
   1. International Diabetes Federation

   IDF Diabetes Atlas, Available from:https://www.idf.org/diabetesatlas. Update 2014; cited 2015 March.
2. ↵
   1. Al-Baghli NA,
   2. Al-Ghamdi AJ,
   3. Al-Turki KA,
   4. Al Elq AH,
   5. El-Zubaier AG,
   6. Bahnassy A

   (2010) Prevalence of diabetes mellitus and impaired fasting glucose levels in the Eastern Province of Saudi Arabia: results of a screening campaign. Singapore Med J 51:923–930.

   OpenUrlPubMed
3. ↵
   1. Association AD

   (2013) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 36(Suppl 1):S67–S74.

   OpenUrlFREE Full Text
4. ↵
   1. Nowotny B,
   2. Zahiragic L,
   3. Krog D,
   4. Nowotny PJ,
   5. Herder C,
   6. Carstensen M,
   7. et al.

   (2013) Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans. Diabetes 62:2240–2248.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Tanti JF,
   2. Jager J

   (2009) Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9:753–762.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Jezewski AJ,
   2. Larson JJ,
   3. Wysocki B,
   4. Davis PH,
   5. Wysocki T

   (2014) A novel method for simulating insulin mediated GLUT4 translocation. Biotechnol Bioeng 111:2454–2465.

   OpenUrl
7. ↵
   1. Tamemoto H,
   2. Kadowaki T,
   3. Tobe K,
   4. Yagi T,
   5. Sakura H,
   6. Hayakawa T,
   7. et al.

   (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Burguete-Garcia AI,
   2. Cruz-Lopez M,
   3. Madrid-Marina V,
   4. Lopez-Ridaura R,
   5. Hernandez-Avila M,
   6. Cortina B,
   7. et al.

   (2010) Association of Gly972Arg polymorphism of IRS1 gene with type 2 diabetes mellitus in lean participants of a national health survey in Mexico: a candidate gene study. Metabolism 59:38–45.

   OpenUrlCrossRefPubMed
9. ↵
   1. Huri HZ,
   2. Makmor-Bakry M,
   3. Hashim R,
   4. Mustafa N,
   5. Wan Ngah WZ

   (2012) Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus. Int J Clin Pharm 34:863–870.

   OpenUrlPubMed
10. ↵
    1. Almind K,
    2. Bjorbaek C,
    3. Vestergaard H,
    4. Hansen T,
    5. Echwald S,
    6. Pedersen O

    (1993) Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828–832.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Morini E,
    2. Prudente S,
    3. Succurro E,
    4. Chandalia M,
    5. Zhang YY,
    6. Mammarella S,
    7. et al.

    (2009) IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency-low-risk’ variants. Diabetologia 52:1852–1857.

    OpenUrl
12. ↵
    1. Martinez-Gomez LE,
    2. Cruz M,
    3. Martinez-Nava GA,
    4. Madrid-Marina V,
    5. Parra E,
    6. Garcia-Mena J,
    7. et al.

    (2011) A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico. Ann Hum Genet 75:612–620.

    OpenUrlCrossRefPubMed
13. ↵
    1. Kommoju UJ,
    2. Maruda J,
    3. Kadarkarai Samy S,
    4. Irgam K,
    5. Kotla JP,
    6. Reddy BM

    (2014) Association of IRS1, CAPN10, and PPARG gene polymorphisms with type 2 diabetes mellitus in the high-risk population of Hyderabad, India. J Diabetes 6:564–573.

    OpenUrl
14. ↵
    1. Arikoglu H,
    2. Aksoy Hepdogru M,
    3. Erkoc Kaya D,
    4. Asik A,
    5. Ipekci SH,
    6. Iscioglu F

    (2014) IRS1 gene polymorphisms Gly972Arg and Ala513Pro are not associated with insulin resistance and type 2 diabetes risk in non-obese Turkish population. Meta Gene 2:579–585.

    OpenUrl
15. 1. Bodhini D,
    2. Radha V,
    3. Mohan V

    (2011) Association Study of IRS1 Gene Polymorphisms with Type 2 Diabetes in South Indians. Diabetes Technol Ther 13:767–772.

    OpenUrlPubMed
16. 1. Feng X,
    2. Tucker KL,
    3. Parnell LD,
    4. Shen J,
    5. Lee YC,
    6. Ordovas JM,
    7. et al.

    (2013) Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study. Asia Pac J Clin Nutr 22:150–159.

    OpenUrlPubMed
17. 1. Vergotine Z,
    2. Kengne AP,
    3. Erasmus RT,
    4. Matsha TE

    (2014) No evidence for association of insulin receptor substrate-1 Gly972Arg variant with type 2 diabetes mellitus in a mixed-ancestry population of South Africa. S Afr Med J 104:420–423.

    OpenUrl
18. ↵
    1. Yiannakouris N,
    2. Cooper JA,
    3. Shah S,
    4. et al.

    (2012) IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk. Nutrition, Metabolism, and Cardiovascular Diseases 22:1024–1030.

    OpenUrlCrossRefPubMed
19. ↵
    1. Yoshimura R,
    2. Araki E,
    3. Ura S,
    4. Todaka M,
    5. Tsuruzoe K,
    6. Furukawa N,
    7. et al.

    (1997) Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling. Diabetes 46:929–936.

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Almind K,
    2. Inoue G,
    3. Pedersen O,
    4. Kahn CR

    (1996) A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97:2569–2575.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. McGettrick AJ,
    2. Feener EP,
    3. Kahn CR

    (2005) Human insulin receptor substrate-1 (IRS-1) polymorphism G972R causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation. J Biol Chem 280:6441–6446.

    OpenUrlAbstract/FREE Full Text
22. ↵
    1. Dziwura J,
    2. Binczak-Kuleta A,
    3. Miazgowski T,
    4. Ziemak J,
    5. Widecka K

    (2011) The associations between G972R polymorphism of the IRS-1 gene, insulin resistance, salt sensitivity and non-dipper hypertension. Hypertens Res 34:1082–1086.

    OpenUrlCrossRefPubMed
23. ↵
    1. Boura-Halfon S,
    2. Zick Y

    (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581–E591.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. Alharbi KK,
    2. Khan IA,
    3. Munshi A,
    4. Alharbi FK,
    5. Al-Sheikh Y,
    6. Alnbaheen MS

    (2014) Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population. Endocrine 47:472–477.

    OpenUrl
25. ↵
    1. Yamada K,
    2. Yuan X,
    3. Ishiyama S,
    4. Shoji S,
    5. Kohno S,
    6. Koyama K,
    7. et al.

    (1998) Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM. Diabetes Care 21:753–756.

    OpenUrlAbstract/FREE Full Text
26. ↵
    1. Thameem F,
    2. Puppala S,
    3. Schneider J,
    4. Bhandari B,
    5. Arya R,
    6. Arar NH,
    7. et al.

    (2012) The Gly(972)Arg Variant of Human IRS1 Gene Is Associated With Variation in Glomerular Filtration Rate Likely Through Impaired Insulin Receptor Signaling. Diabetes 61:2385–2393.

    OpenUrlAbstract/FREE Full Text
27. ↵
    1. Prudente S,
    2. Morini E,
    3. Lucchesi D,
    4. Lamacchia O,
    5. Bailetti D,
    6. Mercuri L,
    7. et al.

    (2014) IRS1 G972R missense polymorphism is associated with failure to oral antidiabetes drugs in white patients with type 2 diabetes from Italy. Diabetes 63:3135–3140.

    OpenUrlAbstract/FREE Full Text
28. ↵
    1. Federici M,
    2. Hribal ML,
    3. Ranalli M,
    4. Marselli L,
    5. Porzio O,
    6. Lauro D,
    7. et al.

    (2001) The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 15:22–24.

    OpenUrlCrossRefPubMed